Fusarium fungaemia in immunocompromised patients

Fusarium infections in immunocompromised patients.

Fusarium species cause a broad spectrum of infections in humans, including superficial, locally invasive, and disseminated infections. The clinical form of fusariosis depends largely on the immune status of the host and the portal of entry, with superficial and localized disease occurring mostly in immunocompetent patients and invasive and disseminated disease affecting immunocompromised patien...

1214Environment as a Potential Source of Fusarium spp. Invasive Infections in Immunocompromised Patients

1214. Environment as a Potential Source of Fusarium spp. Invasive Infections in Immunocompromised Patients Maria Luiza Moretti,; Ariane Busso-Lopes,; Renato Moraes,; Yasunori Muraosa,; Yuzuru Mikami,; Plinio Trabasso,; Kenichiro Tominaga,; Francheline ReichertLima,; Luzia Lyra,; Tohru Gonoi,; Hideaki Taguchi,; Angelica Schreiber,; Katsuhiko Kamei,; University of Campinas, Campinas, Brazil; Medi...

Etiologic Agents of Candidemia in Pediatric Immunocompromised Patients

Abstract Background: Candidemia is the main cause of fungal nosocomial bloodstream infections and is related to meaningful mortality specially, in pediatrics. Mortality rate range from 5% to 71%, and it can reach as high as 81%. Delays in beginning of treatment have also been linked to intensified mortality. The epidemiology of Candida infection is changing from region to region. Regiona...

Norovirus in immunocompromised patients.

W hile undergoing a routine mammogram, Mrs. B, age 76 years and in good health, was found to have right axillary adenopathy. A core biopsy confirmed the diagnosis of follicular lymphoma and she was referred to an oncologist who recommended treatment with six cycles of bendamustine, mitoxantrone, and rituximab. She tolerated the treatment fairly well except for mild lower abdominal discomfort fo...

Vaccines in immunocompromised patients.